Woulgan®

Enhances Macrophage Activity

Woulgan®

Woulgan® Bioactive Beta-Glucan Gel is a treatment for both acute and chronic wounds where wound healing is stalled, or is anticipated to heal slower than normal or is at high risk of becoming stalled. Woulgan® has a unique formulation with gel properties and beta-glucan which reactivates stalled healing and accelerates the healing process[1,2].

 

Product benefits

  • Provides an optimal moist wound-healing environment
  • Re-hydrates necrotic tissue
  • Aids in autolytic debridement
  • Promotes angiogenesis, cell proliferation and wound contraction

References
[1] www.clinicaltrials.gov ID number: NCT 00288392, http://biotec.no/beta-glucans/woulgan-biogel.
[2] Five model studies using Woulgan in wound healing in diabetic mice. Studies performed by a contract research laboratory for Biotec
BetaGlucans.

Woulgan® clinical studies

Author(s) Title Publication
Cutting, K. Health economics of a bioactive beta-glucan gel Wounds UK, 2016, poster View
Cutting, K. The nature of beta-glucans – and the role in wound care of a novel bioactive beta-glucan gel: Woulgan Wounds UK, 2016, poster View
Fitzgerald, R. The clinical and patient experience of using a bioactive beta-glucan gel on a hard-to-heal wound Wounds UK, 2016, poster View
Hepworth, L. Two case studies to demonstrate the use of an innovative bioactive beta-glucan product for the treatment of stalled wounds Wounds UK, 2016, poster View
King, B., Barrett, S. and Cutting, K.F. Clinical evaluation of a bioactive beta-glucan gel in the treatment of ‘hard-to-heal’ wounds Journal of Wound Care, 2017, 26(2) View
Overfield, J. The use of Woulgan to heal a chronic leg ulceration Wounds UK, 2016, poster View
Svetlana, N. Zykova, et al.

Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study

Journal of Diabetes Investigation, 2014, 5(4) View
Welch, D. A clinical evaluation of Woulgan Biogel in the management of non-infected diabetic foot ulcerations The Diabetic Foot Journal, 2017, 20(1)  View
Welch, D. A clinical evaluation of Woulgan in the management of non infected diabetic foot ulcerations Wounds UK, 2016, poster View


References
[1] www.clinicaltrials.gov ID number: NCT 00288392, http://biotec.no/beta-glucans/woulgan-biogel.
[2] Five model studies using Woulgan in wound healing in diabetic mice. Studies performed by a contract research laboratory for Biotec
BetaGlucans.

Woulgan® is indicated for use in stalled, dry or low to medium-exuding partial- or full-thickness wounds:

  • Diabetic foot uclers
  • Leg ulcers (any aetiology)
  • Pressure ulcers
  • Graft and donor sites
  • Open surgical wounds
  • Partial-thickness burns
  • Abrasions and lacerations

 

 

References
[1] www.clinicaltrials.gov ID number: NCT 00288392, http://biotec.no/beta-glucans/woulgan-biogel.
[2] Five model studies using Woulgan in wound healing in diabetic mice. Studies performed by a contract research laboratory for Biotec
BetaGlucans.

Applying Woulgan®

Woulgan® should be applied to a prepared wound bed twice weekly and covered with a suitable secondary dressing.

  • Cleanse wound according to local protocol
  • Debride if required
  • If required protect the wound edges
  • Cover the wound surface with a thin layer of Woulgan®
  • Apply a suitable secondary dressing of choice and fixate
  • Apply compression or offloading if indicated

 

*See product insert leaflet for full instructions for use.


References
[1] www.clinicaltrials.gov ID number: NCT 00288392, http://biotec.no/beta-glucans/woulgan-biogel.
[2] Five model studies using Woulgan in wound healing in diabetic mice. Studies performed by a contract research laboratory for Biotec
BetaGlucans.

Item Size Pieces per box Product code PIP code NHS code
Woulgan® 4g 4 WGA04EA001 ELZ867

 

References
[1] www.clinicaltrials.gov ID number: NCT 00288392, http://biotec.no/beta-glucans/woulgan-biogel.
[2] Five model studies using Woulgan in wound healing in diabetic mice. Studies performed by a contract research laboratory for Biotec
BetaGlucans.